|
1
|
Cancer.org: Testicular cancer: What are
the key statistics about testicular cancer? http://www.cancer.org/Cancer/TesticularCancer/DetailedGuide/testicular-cancer-key-statisticsuri.
Accessed March 19, 2012.
|
|
2
|
Kinkade S: Testicular Cancer. Am Fam
Physician. 59:2539–2544. 1999.PubMed/NCBI
|
|
3
|
Nichols C: Testicular Cancer. Testicular
Cancer Resource Center. http://tcrc.acor.org/iu.htmluri.
Updated May 25, 2010.
|
|
4
|
Hart IR and Fidler IJ: Role of organ
selectivity in the determination of metastatic patterns of B16
melanoma. Cancer Res. 40:2281–2297. 1980.PubMed/NCBI
|
|
5
|
Zeidman I and Busso JM: Transpulmonary
passage of tumor cell emboli. Cancer Res. 12:731–733.
1952.PubMed/NCBI
|
|
6
|
Sugarbaker ED: The organ selectivity of
experimentally induced metastases in rats. Cancer. 5:606–612. 1952.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Inhibition of pulmonary metastasis of
melanoma B16FO cells in C57BL/6 mice by a nutrient mixture
consisting of ascorbic acid, lysine, proline, arginine, and green
tea extract. Exp Lung Res. 32:517–530. 2006. View Article : Google Scholar
|
|
8
|
Gheorgheosu D, Dehelean C, Cristea M and
Muntean D: Development of the B16 murine melanoma model. Annals of
RSCB. 16:148–152. 2011.
|
|
9
|
Niedzwiecki A, Roomi MW, Kalinovsky T and
Rath M: Micronutrient synergy - a new tool in effective control of
metastasis and other key mechanisms of cancer. Cancer Metastasis
Rev. 29:529–543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Roomi MW, Kalinovsky T, Roomi NW,
Monterrey J, Rath M and Niedzwiecki A: Suppression of growth and
hepatic metastasis of murine B16FO melanoma cells by a novel
nutrient mixture. Oncol Rep. 20:809–817. 2008.PubMed/NCBI
|
|
11
|
Koshida K, Konaka H, Imao T, Egawa M,
Mizokami A and Namiki M: Comparison of two in vivo models for
prostate cancer: orthotopic and intratesticular inoculation of
LNCaP or PC-3 cells. Int J Urol. 11:1114–1121. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roomi MW, Kalinovsky T, Niedzwiecki A and
Rath M: Anticancer effects of a micronutrient mixture on melanoma:
modulation of metastasis and other critical parameters.
Breakthroughs in Melanoma Research. Tanaka Y: In Tech Publisher;
ISBN: ISBN 978-953-307-291-32011, View
Article : Google Scholar
|
|
13
|
Fidler IJ: Critical factors in the biology
of human cancer metastasis: twenty-eighth G.H.A. Clowers memorial
award lecture. Cancer Res. 50:6130–6138. 1990.PubMed/NCBI
|
|
14
|
Fang W, Li H, Kong L, Niu G, Gao Q, Zhou
K, Zheng J and Wu B: Role of matrix metalloproteinases (MMPs) in
tumor invasion and metastasis: serial studies on MMPs and TIMPs.
Beijing Da Xue Xue Bao. 35:441–443. 2003.(In Chinese).
|
|
15
|
Liotta LA, Tryggvason K, Garbisa A, Hart
I, Foltz CM and Shafie S: Metastatic potential correlates with
enzymatic degradation of basement membrane collagen. Nature.
284:67–68. 1980. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stetler-Stevenson WG: The role of matrix
metalloproteinases in tumor invasion, metastasis and angiogenesis.
Surg Oncol Clin N Am. 10:383–392. 2001.PubMed/NCBI
|
|
17
|
Duffy MJ: The role of proteolytic enzymes
in cancer invasion and metastasis. Clin Exp Metastasis. 10:145–155.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stetler-Stevenson WG, Hewitt R and
Corcoran M: Matrix metalloproteinases and tumor invasion from
correlation and causality to the clinic. Semin Cancer Biol.
7:174–154. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kleiner DL and Stetler-Stevenson WG:
Matrix metalloproteinases and metastasis. Cancer Chemother
Pharmacol. 43(Suppl): S42–S51. 1999. View Article : Google Scholar
|
|
20
|
Chambers AF and Matrisian LM: Changing
views on the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roomi MW, Monterrey JC, Kalinovsky T, Rath
M and Niedzwiecki A: Inhibition of invasion and MMPs by a nutrient
mixture in human cancer cell lines: a correlation study. Exp Oncol.
32:243–248. 2010.PubMed/NCBI
|
|
22
|
Ivanov V, Ivanova S, Roomi MW, Kalinovsky
T, Niedzwiecki A and Rath M: Naturally produced extracellular
matrix inhibits growth rate and invasiveness of human osteosarcoma
cancer cells. Med Oncol. 24:209–217. 2007. View Article : Google Scholar
|
|
23
|
Rath M and Pauling L: Plasmin-induced
proteolysis and the role of apoprotein(a), lysine and synthetic
analogs. J Orthomolecular Med. 7:17–23. 1992.
|
|
24
|
Sun Z, Chen YH, Wang P, Zhang J, Gurewich
V, Zhang P and Liu JN: The blockage of high-affinity lysine binding
sites of plasminogen by EACA significantly inhibits
prourokinase-induced plasminogen activation. Biochem Biophys Acta.
1596:182–192. 2002.
|
|
25
|
Valcic S, Timmermann BN, Alberts DS,
Wachter GA, Krutzsch M, Wymer J and Guillen JM: Inhibitory effect
of six green tea catechins and caffeine on the growth of four
selected human tumor cell lines. Anticancer Drugs. 7:461–468. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mukhtar H and Ahmed N: Tea polyphenols:
prevention of cancer and optimizing health. Am J Clin Nutr.
71(Suppl 6): S1698–S1702. 2000.PubMed/NCBI
|
|
27
|
Yang GY, Liao J, Kim K, Yurtow EJ and Yang
CS: Inhibition of growth and induction of apoptosis in human cancer
cell lines by tea polyphenols. Carcinogenesis. 19:611–616. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Taniguchi S, Fujiki H, Kobayashi H, Go H,
Miyado K, Sadano H and Shimokawa R: Effect of (−) epigallocatechin
gallate, the main constituent of green tea, on lung metastasis with
mouse B16 melanoma cell lines. Cancer Lett. 65:51–54. 1992.
|
|
29
|
Hare Y: Green Tea: Health Benefits and
Applications. Marcel Dekker; New York, Basel: 2001, View Article : Google Scholar
|
|
30
|
Kawakami S, Kageyama Y, Fujii, Kihara K
and Oshima H: Inhibitory effects of N-acetyl cysteine on invasion
and MMP 9 production of T24 human bladder cancer cells. Anticancer
Res. 21:213–219. 2001.PubMed/NCBI
|
|
31
|
Morini M, Cai T, Aluigi MF, Noonan DM,
Masiello L, De Flora S, D’Agostini F, Albini A and Fassina G: The
role of the thiol N-acetyl cysteine in the prevention of tumor
invasion and angiogenesis. Int J Biol Markers. 14:268–271.
1999.PubMed/NCBI
|
|
32
|
Yoon SO, Kim MM and Chung AS: Inhibitory
effects of selenite on invasion of HT 1080 tumor cells. J Biol
Chem. 276:20085–20092. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maramag C, Menon M, Balaji KC, Reddy PG
and Laxmanan S: Effect of vitamin C on prostate cancer cells in
vitro: effect on cell number, viability and DNA synthesis.
Prostate. 32:188–195. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cooke JP and Dzau VJ: Nitric oxide
synthase: Role in the genesis of vascular disease. Annu Rev Med.
48:489–509. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Roomi MW, Ivanov V, Netke SP, Niedzwiecki
A and Rath M: Serum markers of the liver, heart, and kidney and
lipid profile and histopathology in ODS rats treated with nutrient
synergy. J AM Coll Nutr. 22:477(Abs. 86),. 2003.
|
